DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation
World Journal of Urology · 2026
DOI: 10.1007/s00345-026-06474-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2026. Verfasst von Ubirajara Barroso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Federal University of Bahia, Av Alphaville, 335, Rua Pajuçara, Alphaville 1, Salvador, Bahia, 41701015, Brazil. ubarrosojr@gmail…. Hauptthemen laut MEDLINE: Penis, Phalloplasty, Surgical Flaps, Fascia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Da Bahia.
Abstract (Originalsprache)
Purpose
Dissatisfaction with penile girth is an increasingly recognized concern among men and can cause psychosocial distress despite normal anatomy. Existing augmentation techniques are often associated with limited durability or procedure-related morbidity. This study presents the initial clinical experience with a novel autologous penile girth augmentation technique that combines dartos fascia and tunica vaginalis flap (DART-VAG).
Methods
This was a prospective, non-randomized interventional study evaluating the DART-VAG technique. Penile length and circumference were measured preoperatively and at a 6-month follow-up. Psychosexual outcomes were assessed in a subset of patients using the Degree of Distress due to size concerns (DDC) questionnaire and the Male Genital Self-Image Scale (MGSIS). Postoperative complications and patient satisfaction were prospectively recorded.
Results
Thirty-two adult men underwent penile girth augmentation with DART-VAG between November 2021 and August 2025. No intraoperative complications occurred. Mean penile length increased from 6.2 ± 1.67 cm to 8.7 ± 1.46 cm ( p < 0.001), and mean circumference increased from 9.4 ± 1.08 cm to 11.2 ± 1.15 cm ( p < 0.001). No patient reported loss of achieved dimensions, and all patients (100%) reported satisfaction at 6 months. Wound dehiscence occurred in four patients (12.5%), most of whom were managed conservatively; one patient (3.1%) required surgical drainage of a scrotal hematoma. Total DDC scores decreased significantly after surgery, and MGSIS improved in specific domains.
Conclusions
DART-VAG is a feasible technique for penile girth augmentation, providing significant gains, acceptable complications, and favorable psychosexual outcomes. Larger studies with longer follow-up are needed to confirm our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Federal University of Bahia, Av Alphaville, 335, Rua Pajuçara, Alphaville 1, Salvador, Bahia, 41701015, Brazil. ubarrosojr@gmail.com.
- São Luiz Jabaquara Hospital, São Paulo, Brazil. ubarrosojr@gmail.com.
- Bahiana School of Medicine and Public Health, Salvador, Brazil.
- Division of Urology, Federal University of Bahia, Av Alphaville, 335, Rua Pajuçara, Alphaville 1, Salvador, Bahia, 41701015, Brazil.
- São Luiz Jabaquara Hospital, São Paulo, Brazil.
Förderung
- Universidade Federal Da Bahia
Zitieren
APA
Barroso, U., Barroso, I. A., Ribeiro Filho, G. R., Aguiar Batista, L. T. E., & Lipay, M. A. S. (2026). DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation. World Journal of Urology. https://doi.org/10.1007/s00345-026-06474-2
Vancouver
Barroso U, Barroso IA, Ribeiro Filho GR, Aguiar Batista LTE, Lipay MAS. DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation. World Journal of Urology. 2026. doi:10.1007/s00345-026-06474-2
BibTeX
@article{Barroso2026,
author = {Barroso, Ubirajara and Barroso, Isabela Alvim and Ribeiro Filho, Geraldo Ramos and Aguiar Batista, Lucas Teixeira E and Lipay, Marco Aurélio Silva},
title = {DART-VAG: initial clinical experience with a novel autologous technique for penile girth augmentation},
journal = {World Journal of Urology},
year = {2026},
doi = {10.1007/s00345-026-06474-2}
}
EUVIMED